Company news
Adimmune Corporation news in 2022
Adimmune Corporation's news releases, calls and decks from 2022, newest first.
Adimmune announces financail statements of 2022 second quarter.
August 12, 2022
Adimmune To announce the completion status of execution of the stock repurchase
August 9, 2022
The list of the newly elected 21st directors (including independent directors) of the Company
June 29, 2022
The Company's shareholders' meeting approved the release of non-compete restrictions on directors
June 29, 2022
The Company's board of directors re-elected Dr. Chan Chi-Hsien as the chairperson
June 29, 2022
Announcement of members of the Company's 3rd audit committee
June 29, 2022
Announcement of the board resolution to repurchase treasury shares
June 9, 2022
Resolution by the board of directors not to distribute dividends.
March 29, 2022
The board of directors approved the company's 2021 consolidated financial report.
March 29, 2022
Subject: Announcement of the approval of the Company's quadrivalent influenza vaccine from China's National Medical Products Administration
February 11, 2022
Change to the research and development officer of the company
January 26, 2022